USANA Health Valuation
| USNA Stock | USD 29.44 1.40 4.99% |
At this time, the company appears to be fairly valued. USANA Health Sciences owns a latest Real Value of $28.88 per share. The recent price of the company is $29.44. Our model measures the value of USANA Health Sciences from inspecting the company fundamentals such as return on equity of 0.0642, and Current Valuation of 398.63 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that USANA Health's price fluctuation is very steady at this time. Calculation of the real value of USANA Health Sciences is based on 3 months time horizon. Increasing USANA Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since USANA Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of USANA Stock. However, USANA Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 29.44 | Real 28.88 | Hype 29.44 | Naive 30.96 |
The real value of USANA Stock, also known as its intrinsic value, is the underlying worth of USANA Health Sciences Company, which is reflected in its stock price. It is based on USANA Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of USANA Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of USANA Health Sciences helps investors to forecast how USANA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of USANA Health more accurately as focusing exclusively on USANA Health's fundamentals will not take into account other important factors: USANA Health Total Value Analysis
USANA Health Sciences is at this time estimated to have valuation of 398.63 M with market capitalization of 528.83 M, debt of 29.01 M, and cash on hands of 246.88 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the USANA Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
398.63 M | 528.83 M | 29.01 M | 246.88 M |
USANA Health Investor Information
About 42.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.05. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. USANA Health Sciences has Price/Earnings To Growth (PEG) ratio of 0.94. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 23rd of November 2016. USANA Health Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in June.USANA Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. USANA Health has an asset utilization ratio of 114.21 percent. This suggests that the Company is making $1.14 for each dollar of assets. An increasing asset utilization means that USANA Health Sciences is more efficient with each dollar of assets it utilizes for everyday operations.USANA Health Ownership Allocation
USANA Health Sciences secures a total of 18.86 Million outstanding shares. Over half of USANA Health's outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Also note that nearly five thousand six hundred fifty-eight invesors are currently shorting USANA Health expressing very little confidence in its future performance.USANA Health Profitability Analysis
The company reported the previous year's revenue of 854.5 M. Net Income was 42.06 M with profit before overhead, payroll, taxes, and interest of 705.65 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates USANA Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in USANA Health and how it compares across the competition.
About USANA Health Valuation
The stock valuation mechanism determines USANA Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of USANA Health. We calculate exposure to USANA Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of USANA Health's related companies.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Usana Health operates under Packaged Foods classification in the United States and is traded on New York Stock Exchange. It employs 1978 people.
USANA Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 19.2 M | |
| Quarterly Earnings Growth Y O Y | -0.43 | |
| Forward Price Earnings | 11.274 |
Complementary Tools for USANA Stock analysis
When running USANA Health's price analysis, check to measure USANA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy USANA Health is operating at the current time. Most of USANA Health's value examination focuses on studying past and present price action to predict the probability of USANA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move USANA Health's price. Additionally, you may evaluate how the addition of USANA Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |